This episode focuses on diabetes and COVID-19. Questions are answered regarding the risk for COVID-19 among patients with diabetes, medication concerns in those who test positive for the virus, and the importance of self-monitoring of glucose levels among patients with type 1 and type 2 diabetes.

Questions:

From Shelley Johns, PsyD, HSPP, ABPP, from Indiana University Melvin and Bren Simon Comprehensive Cancer Center:

"Do individuals with diabetes have any added risk of contracting coronavirus, and does this risk vary by their recent blood glucose control?"

From Rachel Pessah-Pollack, MD, from NYU Langone Health:

"Are there any medications that should be stopped if a patient has diabetes and COVID-19?"

"Are glucose levels higher if a patient has diabetes and COVID-19?"

"Is there any additional monitoring that should be done if patients have type 1 diabetes and COVID-19?"

We’d love to hear from you! Send your comments/questions to mailto:[email protected]. Be sure to check Healio.com/coronavirus for daily updates on the pandemic and follow us on Twitter @InfectDisNews and @GoHealio.

Disclosures: Pai reports serving on the advisory boards of Abbvie and Gilead Sciences.